2016 Shingles Vaccine

The shingles vaccine, Zostavax, has been approved to be placed on the National Immunisation Program (NIP), to be provided free of charge from 1 November 2016 to people aged 70 years, subject to vaccine supply. There will also be a five year catch-up program for people aged 71 – 79 years.
Herpes-zoster (Shingles) is a viral infection caused by reactivation of the varicella-zoster (chicken pox) virus, which is a member of the herpes group of viruses. It is usually a mild disease characterised by a painful skin rash with blisters involving a limited area. However, it can be severe in older adults and immunocompromised persons and may cause serious or even fatal complications.